Sachdeva N, Yoon H S, Oshima K, Garcia D, Goodkin K, Asthana D
Laboratory for Clinical and Biological Studies, University of Miami-Miller School of Medicine, Miami, FL 33136, USA.
Scand J Immunol. 2007 Jun;65(6):549-54. doi: 10.1111/j.1365-3083.2007.01906.x.
Assessment of cytokines in body fluids or cells provides important information in understanding the disease process and designing treatment strategies. Recent introduction of antibody-based protein arrays have provided investigators simultaneous and specific detection of multiple analytes in a single sample using minimum volumes. In this study, we used a biochip array system capable of measuring 12 cytokines and growth factors (IL-2, IL-4, IL-6, IL-8, IL-10, IL-1alpha, IL-1beta, IFN-gamma, TNF-alpha, monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF)) in HIV patients with immunological and virological discordance (discordant) to find out differences if any, in their plasma cytokine profiles when compared with concordant HIV-infected individuals. A sandwich chemiluminescent assay was performed with plasma specimens of 110 HIV patients (55 discordant, 55 concordant) and 22 normal healthy individuals followed by enzyme-linked immunosorbent assay (ELISA) to the confirm levels of cytokines and growth factors that showed significant differences in the two groups. The discordant HIV patients showed significantly higher levels of plasma VEGF (P = 0.001) and EGF (P = 0.034) levels when compared with concordant patients. Overall, the patients showed significantly higher levels of TNF-alpha, MCP-1 and VEGF when compared with the normal healthy controls (P < 0.05). ELISA for VEGF (P < 0.001) and EGF (P = 0.004) confirmed the comparison obtained with biochip array, between the discordant and concordant patients. The results of cytokine quantitation by biochip array and ELISA confirmed that this technology is not only comparable but also has a good potential in the future applications involving measurement of multiple cytokines with limiting specimens.
对体液或细胞中的细胞因子进行评估,可为理解疾病进程和制定治疗策略提供重要信息。基于抗体的蛋白质阵列的最新引入,使研究人员能够使用最少的样本量在单个样本中同时特异性检测多种分析物。在本研究中,我们使用了一种能够测量12种细胞因子和生长因子(白细胞介素-2、白细胞介素-4、白细胞介素-6、白细胞介素-8、白细胞介素-10、白细胞介素-1α、白细胞介素-1β、干扰素-γ、肿瘤坏死因子-α、单核细胞趋化蛋白-1(MCP-1)、血管内皮生长因子(VEGF)和表皮生长因子(EGF))的生物芯片阵列系统,来研究免疫和病毒学不一致(不匹配)的HIV患者与匹配的HIV感染者相比,其血浆细胞因子谱是否存在差异。对110例HIV患者(55例不匹配,55例匹配)和22名正常健康个体的血浆样本进行了夹心化学发光测定,随后进行酶联免疫吸附测定(ELISA),以确认两组中显示出显著差异的细胞因子和生长因子水平。与匹配患者相比,不匹配的HIV患者血浆VEGF(P = 0.001)和EGF(P = 0.034)水平显著更高。总体而言,与正常健康对照相比,患者的肿瘤坏死因子-α、MCP-1和VEGF水平显著更高(P < 0.05)。VEGF(P < 0.001)和EGF(P = 0.004)的ELISA结果证实了生物芯片阵列在不匹配和匹配患者之间的比较结果。生物芯片阵列和ELISA对细胞因子定量的结果证实,该技术不仅具有可比性,而且在未来涉及有限样本量的多种细胞因子测量应用中具有良好的潜力。